ID15844A - USE OF INDOLE DESIGNS IN SKIN DISEASE AND TOPICAL COMPOSITION THAT CONTAINS IT - Google Patents

USE OF INDOLE DESIGNS IN SKIN DISEASE AND TOPICAL COMPOSITION THAT CONTAINS IT

Info

Publication number
ID15844A
ID15844A IDP970191A ID970191A ID15844A ID 15844 A ID15844 A ID 15844A ID P970191 A IDP970191 A ID P970191A ID 970191 A ID970191 A ID 970191A ID 15844 A ID15844 A ID 15844A
Authority
ID
Indonesia
Prior art keywords
indole
designs
topical composition
skin disease
disease
Prior art date
Application number
IDP970191A
Other languages
Indonesian (id)
Inventor
Katrin Dr Kriwet
Neil Stewart Dr Ryder
Andreas Dr Werner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601297.6A external-priority patent/GB9601297D0/en
Priority claimed from GBGB9601294.3A external-priority patent/GB9601294D0/en
Priority claimed from GBGB9610225.6A external-priority patent/GB9610225D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID15844A publication Critical patent/ID15844A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP970191A 1996-01-23 1997-01-23 USE OF INDOLE DESIGNS IN SKIN DISEASE AND TOPICAL COMPOSITION THAT CONTAINS IT ID15844A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9601297.6A GB9601297D0 (en) 1996-01-23 1996-01-23 Organic compounds
GBGB9601294.3A GB9601294D0 (en) 1996-01-23 1996-01-23 Organic compounds
GBGB9610225.6A GB9610225D0 (en) 1996-05-16 1996-05-16 Organic compounds

Publications (1)

Publication Number Publication Date
ID15844A true ID15844A (en) 1997-08-14

Family

ID=27268088

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970191A ID15844A (en) 1996-01-23 1997-01-23 USE OF INDOLE DESIGNS IN SKIN DISEASE AND TOPICAL COMPOSITION THAT CONTAINS IT

Country Status (3)

Country Link
AU (1) AU1593797A (en)
ID (1) ID15844A (en)
WO (1) WO1997026874A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801508B1 (en) * 1999-11-29 2003-11-14 Oreal USE OF HMG COA-REDUCTASE INHIBITORS FOR THE TREATMENT OF SEBORRHEA
US20020010128A1 (en) * 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
JP4630065B2 (en) * 2002-09-20 2011-02-09 興和株式会社 Topical preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738510A3 (en) * 1995-04-20 2005-12-21 L'oreal Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties.

Also Published As

Publication number Publication date
AU1593797A (en) 1997-08-20
WO1997026874A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
ID21694A (en) METHODS AND COMPOSITIONS TO REDUCE FINE SKINS AND SKINS ON SKIN
ID26540A (en) USE OF MICROPIGMEN MIXTURE TO PREVENT LOCATION AND TO STRENGTHEN SKIN AND HAIR
BR9702553A (en) Cosmetic composition and use
ID17156A (en) ANTI-COAGULAN SUBSTANCE USE IN TREATMENT OF TROMBOSIS
IL130037A0 (en) Use of sphingomyelinase to increase the levels of skin and mucosal cermides and dermatological and cosmetic compositions suitable for topical application containing same
ID17437A (en) METHODS AND COMPOSITIONS TO MAKE LIGHT SKIN
NO993979D0 (en) Procedures to prevent and delay the onset of Alzheimer's disease and its composition
IS5405A (en) Prostaglandin agonists and their use in the treatment of bone disorders
IS5157A (en) Arylsulfonamide and their analogues and their use in the treatment of neurodegenerative disorders
ID17116A (en) COMPOSITION OF 6-FENILPIRIDYL-2-AMINE COMPOUNDS AND ITS USE IN TREATMENT AND DISORDERS OF CENTRAL NERVOUS SYSTEMS
ZA958445B (en) Compositions for topical application to skin hair and nails
ID26725A (en) SUBSTANCE TO PREVENT AND TREAT SKIN DISEASE
DE69836008D1 (en) COMPOSITION AND TREATMENT AGENT
ID22565A (en) USE OF NANODISPERION IN FINAL DRUG FORMULATION
ID24652A (en) COMPOSITION FOR USE IN PERSONAL CARE
ID18629A (en) COMPOSITION OF CATALYST USING USE IN NO SATURDAY HYDROGENATION
FI972546L (en) Cross-linked microparticles and their use as therapeutic excipients
HUP0004685A3 (en) Cleanser composition for skin and hair care
HUP9800801A3 (en) Hair care cosmetic compositions and use thereof
AU8905098A (en) Skin care compositions and use
BR9702054A (en) Cosmetic composition process of cosmetic treatment of keratin materials and use of the composition
BR9707623A (en) Cosmetic composition process of cosmetic treatment of keratin materials and use of the composition
DE69829781D1 (en) SKIN AND HAIR-TINGING COMPOSITION
ID20819A (en) HUMAN SEMAFORINS (H-SEMA L) AND SEMAFORINS ACCORDING TO OTHER SPECIES
NO20003410D0 (en) Preparation and use of mixed opalescent agents based on titanium and silica